After news broke on Monday of Pfizer’s coronavirus vaccine candidate reaching over 90% efficacy in a clinical trial, an expert from a large hospital network in New York voiced cautious optimism over an approaching vaccine. “In regards to the Pfizer news, we are cautiously optimistic that a vaccine is within reach.
We are eager to see the trial's full details, but the news is certainly encouraging," Dr. Mark Jarrett, the chief quality officer at Northwell Health, which serves New York City, Long Island, and Westchester, N.Y., told Fox News. "...We are cautiously optimistic that a vaccine is within reach," one expert said.(iStock) “Before any decisions are made, researchers and doctors need to validate the efficacy, safety and ability to.